A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

NCT00517634 ·Status: COMPLETED ·Phase: PHASE4

A Trial to Assess the Pharmacodynamic Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01168310 ·Status: COMPLETED ·Phase: PHASE2

A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD

NCT01376245 ·Status: COMPLETED ·Phase: PHASE3

Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease

NCT00268177 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing the Closed Triple Therapy, Open Triple Therapy and a Dual Therapy for Effect on Lung Function in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02731846 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients

NCT03774290 ·Status: COMPLETED ·Phase: PHASE2

Shortness Of Breath Questionnaire Validation Study

NCT00411372 ·Status: WITHDRAWN ·Phase: PHASE3

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01054170 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

NCT01436110 ·Status: COMPLETED ·Phase: PHASE3

Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients

NCT00830102 ·Status: COMPLETED ·Phase: PHASE2

An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease

NCT02366637 ·Status: TERMINATED ·Phase: PHASE2

A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma

NCT04665895 ·Status: COMPLETED ·Phase: PHASE3

To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma

NCT05363202 ·Status: UNKNOWN ·Phase: PHASE3

Phase IV O2 Consumption Study in COPD Patients.

NCT02533505 ·Status: COMPLETED ·Phase: PHASE4

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

NCT02437604 ·Status: COMPLETED ·Phase: PHASE1

A Study in Asthmatic Patients to Determine if There is Any Difference in Dosing With Fluticasone Furoate/Vilanterol Inhalation Powder in the Morning or Evening on Lung Function

NCT01287065 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component

NCT02164539 ·Status: COMPLETED ·Phase: PHASE2

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT02729051 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma

NCT01837316 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Study of Fluticasone Furoate (FF)/GW642444 Inhalation Powder and the Individual Components in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT01054885 ·Status: COMPLETED ·Phase: PHASE3

Salmeterol/Fluticasone Easyhaler in the Treatment of Asthma and COPD

NCT03755544 ·Status: COMPLETED

Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00422604 ·Status: COMPLETED ·Phase: PHASE2

Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product

NCT00291382 ·Status: COMPLETED ·Phase: PHASE4

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease

NCT02157935 ·Status: COMPLETED ·Phase: PHASE3

Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics

NCT00364442 ·Status: COMPLETED ·Phase: PHASE1